
Mikaso 500mg Injection
Marketer
Bison Biotec Pvt Ltd
Salt Composition
Amikacin (500mg)
Overview Mikaso 500mg Injection
Klavocin 500mg Injection is a broad-spectrum antibiotic combating various bacterial infections. These encompass urinary tract, bone, joint, lung (including pneumonia), brain, and bloodstream infections, among others. Prophylactic use is also indicated in hospitalized patients. Klavocin 500mg Injection inhibits bacterial growth. Administered intravenously (IV drip) or intramuscularly by a healthcare professional only, self-injection is strictly prohibited. Consistent, evenly spaced dosing as directed is crucial. Complete the prescribed course, regardless of symptom improvement; premature cessation risks relapse or infection exacerbation. Common adverse effects include injection site reactions and elevated blood urea nitrogen. Persistent side effects or treatment ineffectiveness warrant medical consultation. High-dose therapy may rarely cause vertigo, nephrotoxicity, and ototoxicity. Strict adherence to physician instructions is paramount, potentially including regular kidney function, hearing, and urinalysis. This medicine is contraindicated during pregnancy. Disclose pregnancy, pregnancy planning, or breastfeeding to your doctor.
Uses of Mikaso 500mg Injection
Infections caused by bacteria
Major Benefits of Mikaso 500mg Injection:
Administering this medication will be done by your physician or their nursing staff; self-medication is strictly prohibited.
Common Side effects of Mikaso 500mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Mikaso 500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Mikaso 500mg Injection works:
Mikaso 500mg Injection is a bacterial growth inhibitor. Its antibiotic action arises from blocking the production of crucial bacterial proteins, thereby disrupting essential cellular processes.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Mikaso 500mg Injection presents no known adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Administering Mikaso 500mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Mikaso 500mg Injection poses minimal risk during lactation. Research in humans indicates negligible transfer of the medication into breast milk, presenting no apparent danger to the infant.
DrivingUNSAFE
Administering Mikaso 500mg Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects manifest.
KidneyCAUTION
For individuals with impaired kidney function, administering Mikaso 500mg Injection requires careful consideration. The prescribed dosage of Mikaso 500mg Injection might require modification. A physician's consultation is recommended.
LiverSAFE IF PRESCRIBED
Mikaso 500mg Injection is likely safe for individuals with hepatic impairment. Available evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Mikaso 500mg Injection :
Omit a Mikaso 500mg Injection dose? Seek your physician's advice.
Facts to Know About Mikaso 500mg Injection
| Label | Value |
|---|---|
| Type of Compound | Amino-glycoside antibiotics |
| Potential for Dependence | None. |
| Medication Category | Antimicrobial agents |
| Mechanism of Action | Aminoglycoside antibiotics |
